Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 26, 2025, titled "Press Release regarding receipt of USFDA Approval.".
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 26, 2025, titled "Press Release regarding receipt of USFDA Approval.".